Hepatitis B surface antigen (HBsAg) prevalence in Angola
Angola: Hepatitis B surface antigen (HBsAg) prevalence was 3.1% in 2024. ▲ Rising
Latest (2024)
3.1%
Change on year
unchanged
World rank
5th
of 194 countries
All-time high
3.1%
in 2022
All-time low
2.5%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Angola, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Angola recorded 3.1% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the highest value across all 10 years on record.
The figure is up 24.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Angola peaked at 3.1% in 2022 and was at its lowest, 2.5%, in 2015.
Angola ranks 5th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Angola, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.5% | — |
| 2016 | 2.6% | +4.0% |
| 2017 | 2.6% | +0.0% |
| 2018 | 2.7% | +3.8% |
| 2019 | 2.8% | +3.7% |
| 2020 | 2.9% | +3.6% |
| 2021 | 3.0% | +3.4% |
| 2022 | 3.1% | +3.3% |
| 2023 | 3.1% | +0.0% |
| 2024 | 3.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.6% | 2.5% | 2.8% | 5 |
| 2020s | 3.0% | 2.9% | 3.1% | 5 |
Countries ranked near Angola
More health data for Angola
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.05 % change on previous year (2090)
- Heat deaths vs projected death rates 740.2 (2090)
- Un projection of annual infant deaths 31,754 (2100)
- Population ages 65 and above, female, annual growth rate 4.57 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0163 units per person (2025)
- Population ages 65 and above, male, annual growth rate 4.59 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0126 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Angola?
- Hepatitis b surface antigen (hbsag) prevalence in Angola was 3.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Angola?
- The highest recorded value was 3.1% in 2022.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Angola?
- The lowest recorded value was 2.5% in 2015.
- How does Angola rank for hepatitis b surface antigen (hbsag) prevalence?
- Angola ranks 5th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Angola?
- Over the last ten years it is up 24.0%. The long-run trend across the full record is rising.
- Where does this Angola data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).